These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4648992)

  • 21. Influence of dexamethasone on the recrudescence of Anaplasma marginale in splenectomized calves.
    Kuttler KL; Adams LG
    Am J Vet Res; 1977 Sep; 38(9):1327-30. PubMed ID: 921027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of a bovine Theileria.
    Kuttler KL; Craig TM
    Am J Vet Res; 1975 Mar; 36(3):323-5. PubMed ID: 804831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effect of a dithiosemicarbazone on acute infections of Anaplasma marginale.
    Roby TO; Amerault TE; Spindler LA
    Res Vet Sci; 1968 Nov; 9(6):494-9. PubMed ID: 5719106
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Anaplasma marginale infection upon blood gases and electrolytes in splenectomized calves.
    Allen PC; Kuttler KL
    J Parasitol; 1981 Dec; 67(6):954-6. PubMed ID: 7328469
    [No Abstract]   [Full Text] [Related]  

  • 26. Imidocarb dipropionate in the treatment of Anaplasma marginale in cattle: Effects on enzymes of the antioxidant, cholinergic, and adenosinergic systems.
    Doyle RL; Fritzen A; Bottari NB; Alves MS; da Silva AD; Morsch VM; Schetinger MR; Martins JR; Santos JS; Machado G; da Silva AS
    Microb Pathog; 2016 Aug; 97():226-30. PubMed ID: 27301742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF; Kocan KM; Higgins JJ; Apley MD; Jones DE
    Vet Microbiol; 2009 Apr; 136(1-2):45-53. PubMed ID: 19054634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of acute bovine anaplasmosis.
    Wilson AJ; Parker R; Parker M; Hall WT; Trueman KF
    Aust Vet J; 1979 Feb; 55(2):71-3. PubMed ID: 444164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of various chemotherapeutic agents in experimental bovine anaplasmosis.
    Sharma SK; Banerjee DP; Gautam OP
    Ann Rech Vet; 1977; 8(3):307-13. PubMed ID: 606144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolipoidemia and hypergammaglobulinemia associated with experimentally induced anaplasmosis in calves.
    Buening GM
    Am J Vet Res; 1974 Mar; 35(3):371-4. PubMed ID: 4362213
    [No Abstract]   [Full Text] [Related]  

  • 32. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of drugs in bovine anaplasmosis.
    Mishra AK; Sharma NN
    Trop Anim Health Prod; 1979 Nov; 11(4):222-6. PubMed ID: 552672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immune responses in calves with anaplasmosis.
    Buening GM
    Am J Vet Res; 1973 Jun; 34(6):757-63. PubMed ID: 4707561
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of the oxitetracycline in the increase of the packed cell volume of cows milk jugs during outbreak of bovine anaplasmosis].
    Gotze MM; Nizoli LQ; Silva SS
    Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():92-5. PubMed ID: 20059824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF; Apley MD; Kocan KM; Jones DE
    J Vet Pharmacol Ther; 2006 Jun; 29(3):173-83. PubMed ID: 16669861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine anaplasmosis: in utero transmission and the immunologic significance of ingested colostral antibodies.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1984 Mar; 45(3):440-3. PubMed ID: 6711971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative persistence of capillary tube-agglutination and complement-fixation test reactions in cattle treated to destroy the carrier state of anaplasmosis.
    Jatkar PR; Kreier JR; Akin EL; Tharp V
    Am J Vet Res; 1966 Jan; 27(116):372-4. PubMed ID: 5950165
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphologic alteration of Anaplasma marginale in calves treated with a dithiosemicarbazone.
    Simpson CF; Neal FC
    Am J Vet Res; 1982 Nov; 43(11):1903-6. PubMed ID: 7181188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.